Events

Upcoming Events

No events are scheduled at this time. Check back for future event information.


Past Events

RSESS Webinar

Webinar

Update: The UK’s Medicines and Healthcare Products Regulatory Agency

Speaker(s):
David R. Jones, Retired, Expert PharmacoToxicologist, Medicines and Healthcare products Regulatory Agency

Materials:
Webinar Recording
David R. Jones Presentation

September 13, 2023

1 hour 30 minutes

RSESS Webinar

Webinar

Risk Evaluation of Nongenotoxic Carcinogenic Pharmaceuticals: Impact of The ICH S1B Addendum, A European Viewpoint

Speaker(s):
Jan Willem van der Laan, PhD, Medicines Evaluation Board, European Medicines Agency Representative, ICH S1 Carcinogenicity Regulatory Chair

Materials:
Webinar Recording
van der Laan Presentation

January 17, 2023

1 hour 30 minutes

BTSS and RSESS Joint Webinar

Webinar

Considerations Regarding Nonhuman Primate Use in Pharmaceutical Development

Speaker(s):
Ronald Wange, PhD, Associate Director for Pharmacology and Toxicology, OND, CDER

Materials:
Webinar Recording
Wange Presentation

Thursday, September 22, 2022

1 hour 30 minutes

RSESS Webinar

Webinar

Safety of COVID-19 Therapies and Vaccines

Speaker(s):
Kenneth L. Hastings, DrPH, DABT, ATS, Hastings Toxicology Consulting LLC

Materials:
Webinar Recording
Hastings Presentation

Tuesday, June 21, 2022

1 hour 30 minutes

RSESS Virtual Event

Webinar

Membership Meet & Greet 2022

Wednesday, May 4, 2022

1 hour

LORC & RSESS Webinar

Webinar

Cannabis: A Review of the Current State of Safety and Regulatory Considerations

Speaker(s):
Tom Jonaitis, DABT
Garrett Graff, Esq.

Materials:
Webinar Recording
Tom Jonaitis, DABT Presentation
Garrett Graff, Esq. Presentation

February 28, 2020

1 hour 15 minutes

RSESS Webinar

Webinar

Assessment of Adversity and NOAEL in Toxicology Studies to Support Regulatory Decision

Speaker(s):
John L. Vahle, DVM, PhD, DACVP
Vincent Meador, DVM, PhD, DACVP

Materials:
Webinar Recording (Unavailable)
Dr. Vahle Presentation
Dr. Meador Presentation

October 2018

1 hour

GSLC & RSESS Webinar

Webinar

Finding Your Dream Job in Regulatory Toxicology

Speaker(s):
Edward V. Ohanian, PhD
Amy L. Roe, PhD, DABT
Anne E. Loccisano, PhD, DABT

Materials:
Webinar Recording (Unavailable)
Dr. Ohanian Presentation
Dr. Roe Presentation
Dr. Loccisano Presentation

October 2017

1 hour 32 minutes

RSESS Webinar

Webinar

Updates for FDA’s GLP Regulations

Speaker(s):
Mark Seaton, PhD, DABT, US FDA

Materials:
Webinar Recording (Unavailable)
Dr. Seaton Presentation

September 2017

1 hour 15 minutes

Regulatory Breakfast Session—RSESS SOT Annual Meeting

Meeting

First-in-human studies: Recent experiences in Europe

Speaker(s):
Jan Willem van der Laan, Medicines Evaluation Board, Utrecht, The Netherlands
David Jones, MHRA, London, United Kingdom

Materials:
Jan Willem van der Laan Presentation
Lutz Müller Presentation

March 2017

RSESS Webinar

Webinar

EPA’s Guidelines and Other Related Activities for Cyanotoxins

Speaker(s):
Lesley V. D’Anglada, DrPH, MEH, US Environmental Protection Agency, Washington, DC

February 2017

Great Debate—RSESS SOT Annual Meeting

Meeting

Precautionary Principle = Risk Assessment (or Not)?

Speaker(s):
Professor Christopher Portier, PhD, FASA, FISI, FWIF, Thun, Switzerland
Professor Alan R. Boobis, OBE, PhD, FRSB, FBTS, Imperial College, London, UK

March 2016

Global Regulations Breakfast—RSESS SOT Annual Meeting

Meeting

CTA/NDA Regulatory Landscape in China

Speaker(s):
Dr. Jianxun (Jack) Xie, PhD, DABT, Director, Head of Toxicology, Roche Innovation Center Shanghai (China)

Materials:
Presentation

March 2016

RSESS Webinar—Joint Risk Assessment

Webinar

The Integration of LNT and Hormesis for Cancer Risk Assessment Optimizes Public Health Protection

Speaker(s):
Edward J. Calabrese, Ph.D.

Materials:
Webinar Recording (Unavailable)
Presentation

October 2015

Brown Bag Luncheon—RSESS SOT Annual Meeting

Meeting

Global Regulatory Toxicology: First Stop EU

Speaker(s):
Beatriz Silva Lima, Universidade de Lisboa, PT, IMI Scientific Committee, BE, NDA Advisory Board, UK

Materials:
Presentation

March 2015

Great Debate—RSESS SOT Annual Meeting

Meeting

Can/Should Peer-Reviewed Publications Be Used to Formulate Regulatory Policy?

 

March 2015

Great Debate—RSESS SOT Annual Meeting

Meeting

HA Mutagen Is a Carcinogen Because It Is a Mutagen

 

March 2014

Great Debate—RSESS SOT Annual Meeting

Meeting

Hazard Information Provides an Adequate Basis for Restricting Chemical Use

Speaker(s):
RSESS Past President James C. Lamb, IV, of Exponent
George Gray, George Washington University
Lorenz Rhomberg, Gradient Corporation

Materials:
Debate Flyer

March 2011

Great Debate—RSESS SOT Annual Meeting

Meeting

Are the Blind Leading the Blind or Are Pathologists Biased? A Debate on the Pros and Cons of Blinded Histopathology Evaluation for the Qualification of New Biomarkers of Toxicity

Speaker(s):
B. Short
K. Pandher
B. Maronpot

Materials:
B. Short Presentation
K. Pandher Presentation
B. Maronpot Presentation

March 2010

Great Debate—RSESS SOT Annual Meeting

Meeting

Limit the Use of the Non-Rodent in Toxicity Testing: Scientific Considerations

Speaker(s):
Monticello
Olson

Materials:
Monticello Presentation
Olson Presentation

March 2009

Great Debate—RSESS SOT Annual Meeting

Meeting

MTD: Is Testing to the MTD Unnecessary Animal Use or Always Necessary to Assure Human Safety?

Speaker(s):
Reynolds
Osterberg
Sistare

Materials:
Reynolds Presentation
Osterberg Presentation
Sistare Presentation

March 2008

Great Debate—RSESS SOT Annual Meeting

Meeting

Ten Years after the Food Quality Protection Act: Healthier Children or Unnecessary Burden?

Speaker(s):
Fenner-Crisp
Faustman
Bus

Materials:
Fenner-Crisp Presentation
Faustman Presentation
Bus Presentation

March 2007

Great Debate—RSESS SOT Annual Meeting

Meeting

Animal and Human Testing: What’s Appropriate?

Speaker(s):
Doull
Sandusky
Rodricks

Materials:
Doull Presentation
Sandusky Presentation
Rodricks Presentation

March 2006

Great Debate—RSESS SOT Annual Meeting

Meeting

Rodent Carcinogenicity Assay: Relevant or Relic?

Speaker(s):
Dr. Cohen
Dr. Jacob

Materials:
The Great Debate
Dr. Cohen’s Presentation
Dr. Jacob’s Carcinogenicity Prediction Article

March 2005

Great Debate—RSESS SOT Annual Meeting

Meeting

Positive Genetic Toxicity Findings: Now What?

Speaker(s):
David Kram
Galloway
Gary Williams

Materials:
David Kram Presentation
Galloway Presentation
Gary Williams Presentation

March 2004